Elevated serum interleukin-41 levels as a potential biomarker in ankylosing spondylitis

This study indicates that serum IL-41 levels are elevated in both active and inactive AS patients, suggesting that IL-41 may be a novel biomarker for AS.

Authors

Institutions

Publication Details

Journal
Future Science OA
Published
2025-08-18
DOI
https://doi.org/10.1080/20565623.2025.2545732
Primary Topic
Spondyloarthritis Studies and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Elevated serum interleukin-41 levels as a potential biomarker in ankylosing spondylitis

Mingcai Li, Shanjun Shi, Zhi Li, Sicen Meng et al.
Future Science OA
Spondyloarthritis Studies and Treatments
article

Elevated serum interleukin-41 levels as a potential biomarker in ankylosing spondylitis

Mingcai Li, Shanjun Shi, Zhi Li, Sicen Meng, Jieru Pang, Wubing Lu
article en

Abstract

This study indicates that serum IL-41 levels are elevated in both active and inactive AS patients, suggesting that IL-41 may be a novel biomarker for AS.

Future Science OAVol. 11(1)
Ningbo University (CN), Ningbo University Affiliated Hospital (CN)
Natural Science Foundation of Ningbo
Zero hunger
Openalex Percentile: Top 68%
Spondyloarthritis Studies and Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Elevated serum interleukin-41 levels as a potential biomarker in ankylosing spondylitis — Mingcai Li, Shanjun Shi, et al. · Future Science OA (2025) | TGRS Research Map | TGRS